相关实验视频
Updated: Jun 27, 2026

05:44
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
10.0K
复杂的脱血疗法在性腺炎supurativa相关的生殖器淋巴 edem:一个案例报告
Ayşegül Yaman1, Pınar Borman2, Pelin Eşme3
1Department of Physical Medicine and Rehabilitation, University of Health Sciences, Gülhane Training and Research Hospital, Ankara, Turkey.
Journal of wound care
|February 7, 2024
概括
复杂的脱血疗法 (CDT) 提供了一个有前途的,快速治疗性腺淋巴引起的性腺炎supurativa (HS). 这份案例报告突出了CDT的重点.
科学领域:
- 皮肤病学 皮肤病学
- 血管外科 血管外科
- 在瘤学瘤学.
背景情况:
- 生殖器淋巴 edem 是一个罕见的,使人虚弱的复杂性 hidradenitis suppurativa (HS).
- 对于与HS相关的生殖器淋巴瘤,存在有限的治疗选择.
- 没有关于这种情况的复杂脱血疗法 (CDT) 的数据.
研究的目的:
- 用CDT描述与HS相关的生殖器淋巴 edem的治疗和结果.
- 评估CDT在对其他疗法没有反应的患者的疗效.
主要方法:
- 一份病例报告显示,一名56岁的男性因HS (Hurley第3阶段) 患有严重的阴囊淋巴.
- 同时使用CDT (每周3次) 和ixekizumab治疗HS.
- 患者和妻子的自我排水和护肤教育.
主要成果:
- 在14天内进行6次CDT疗程后,阴囊测量显著减少.
- 改善阴囊轮和减少埋藏的阴茎.
- 更容易和无痛的排尿.
结论:
- CDT是一种易于应用,实用且有前途的方法,用于与HS相关的生殖器淋巴.
- CDT提供了快速的治疗反应.
- 这种方法可以显著改善患者的生活质量.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

